Diuretic-Induced Myopathy: Clinical Implications and Prevention

Mechanism and Risk Factors

Diuretics, particularly loop diuretics and thiazides, cause increased delivery of sodium to distal tubules, enhancing exchange of sodium for other cations including potassium and magnesium, as noted by the American College of Cardiology and other guideline societies 1, 2
This electrolyte depletion is further potentiated by activation of the renin-angiotensin-aldosterone system, according to Circulation 3, 2
Hypomagnesemia frequently coexists with hypokalemia and contributes to muscle dysfunction, as reported by the American College of Cardiology and Praxis Medical Insights 2
Combination therapy with loop and thiazide diuretics significantly increases the risk of diuretic-induced myopathy, as stated by Circulation 3
Pre-existing renal impairment is a risk factor for diuretic-induced myopathy, as noted by the American College of Cardiology and Circulation 3, 4

Regular monitoring of serum electrolytes, particularly potassium and magnesium, during diuretic therapy is recommended by Circulation and the Journal of Hepatology 3, 5
Concomitant administration of ACE inhibitors or potassium-sparing diuretics, such as spironolactone, can help prevent electrolyte depletion, as suggested by the American College of Cardiology and Circulation 1, 3
Potassium supplements may be necessary in patients with hypokalemia, but are often not needed when potassium-sparing agents are used, according to the American College of Cardiology and Circulation 3, 4
Severe cases of hypomagnesemia may require magnesium supplementation, as reported by Praxis Medical Insights 2